Clinical Trial Update: Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

View source ↗

Summary

This clinical trial update notes the completion of a Special Clinical Experience Investigation evaluating the long-term use of Symbicort Turbuhaler in COPD pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort Turbuhaler 30/60 (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED